Alligator Bioscience
0.031
SEK
0 %
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
0%
+45.24%
+45.82%
-48.13%
-72.53%
-71.59%
-75.99%
-92.38%
-98.21%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
886.3M SEK
Turnover
195.96K SEK
Revenue
57.77M
EBIT %
-396.64 %
P/E
-
Dividend yield-%
-
Financial calendar
24.4
2025
Interim report Q1'25
5.7
2025
General meeting '25
10.7
2025
Interim report Q2'25
ShowingAll content types
Alligator Bioscience: BioStock: Alligator's CEO: "I'm confident that we will strike a deal"
Alligator Bioscience Announces Publication of Clinical Data for ATOR-1017 (evunzekibart) in the Journal for ImmunoTherapy of Cancer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools